Draegerwerk AG & Co. KGaA (DRW3) AI Stock Analysis

• Market Cap: €1.58B
• Dividend Yield: 2.95%
• Average Volume (3M): 7.90K
• Price to Earnings (P/E): 9.3
• Beta (1Y): 0.53
• Revenue Growth: 2.14%
• EPS Growth: 6.69%
• Country: DE
• Employees: 15,444
• Sector: Healthcare
• Sector Strength: 45
• Industry: Medical - Devices
• EPS (TTM): 4.99
• Shares Outstanding: 8,600,000
• 10 Day Avg. Volume: 7,731
• 30 Day Avg. Volume: 7,901
• PEG Ratio: 0.74
• Price to Book (P/B): 0.80
• Price to Sales (P/S): 0.37
• P/FCF Ratio: 7.81
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: €91.50
• Price Target Upside: 5.78% Upside
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 3
• EPS Forecast (FY): 7.97
• Revenue Forecast (FY): €3.63B

• Rating: 76 Outperform
• Price Target: €105.00 ▲(21.39% Upside)
• Action: Reiterated Date: 03/25/26
• Date: Action: Reiterated 03/25/26

Overall score is driven primarily by improving financial health (low leverage and a return to positive profitability) and attractive valuation (low P/E with a dividend). Technicals add support with the stock trading above major moving averages and positive momentum indicators, while the main offset is still-thin margins and historically inconsistent cash-flow conversion.

Positive Factors

Balance Sheet Health

A low debt-to-equity (~0.20) and growing equity provide durable financial flexibility. This reduces refinancing risk, supports steady investment in R&D and service infrastructure, and gives the company room to fund capex, dividends or opportunistic M&A through cycles.

Negative Factors

Margin Pressure / Profitability

Relatively thin net and EBITDA margins limit earnings resilience and the ability to absorb input-cost inflation. Lower margin headroom constrains reinvestment and reduces returns on new initiatives, meaning sustainable EPS growth requires either margin expansion or material top-line acceleration.

Draegerwerk AG & Co. KGaA Business Overview & Revenue Model

Company Description

Drägerwerk AG & Co. KGaA operates as a medical and safety technology company in Europe, the Americas, Africa, Asia, and Australia. The company develops, produces, and markets system solutions, equipment, and services for acute point of care, inclu...

Read more

Drägerwerk AG & Co. KGaA operates as a medical and safety technology company in Europe, the Americas, Africa, Asia, and Australia. The company develops, produces, and markets system solutions, equipment, and services for acute point of care, inclu...

How the Company Makes Money

Dräger generates revenue primarily through the sale of products and associated services across two main segments: Medical and Safety. In the Medical segment, the company earns money from selling hospital and acute-care equipment (e.g., anesthesia ...

Read more

Dräger generates revenue primarily through the sale of products and associated services across two main segments: Medical and Safety. In the Medical segment, the company earns money from selling hospital and acute-care equipment (e.g., anesthesia ...

Draegerwerk AG & Co. KGaA Financial Statement Overview

Breakdown	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	3.48B	3.37B	3.37B	3.05B	3.33B
Gross Profit	1.52B	1.51B	1.46B	1.24B	1.54B
EBITDA	384.83M	351.68M	318.33M	62.63M	374.43M
Net Income	139.50M	124.41M	110.43M	-64.56M	154.23M
Balance Sheet
Total Assets	3.28B	3.09B	3.09B	3.11B	3.18B
Cash, Cash Equivalents and Short-Term Investments	284.06M	248.18M	279.36M	319.50M	577.38M
Total Debt	405.11M	395.58M	471.38M	361.95M	348.01M
Total Liabilities	1.65B	1.56B	1.69B	1.79B	1.92B
Stockholders Equity	1.63B	1.54B	1.41B	1.32B	1.26B
Cash Flow
Free Cash Flow	166.50M	103.52M	121.47M	-231.09M	274.54M
Operating Cash Flow	238.33M	167.31M	189.68M	-144.23M	384.89M
Investing Cash Flow	-98.15M	-43.39M	-67.34M	36.83M	-109.92M
Financing Cash Flow	-83.99M	-161.38M	-154.56M	-29.38M	-334.64M

Draegerwerk AG & Co. KGaA Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 86.50
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For DE:DRW3, the sentiment is Positive. The current price of 86.5 is below the 20-day moving average (MA) of 90.54, below the 50-day MA of 89.51, and above the 200-day MA of 74.93, indicating a bullish trend. The MACD of 1.67 indicates Negative momentum. The RSI at 62.43 is Neutral, neither overbought nor oversold. The STOCH value of 77.22 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for DE:DRW3.

Draegerwerk AG & Co. KGaA Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
DRW3	76 Outperform	€1.58B	9.32	9.11%	2.95%	2.14%	6.69%
EUZ	67 Neutral	€933.60M	19.58	20.78%	1.11%	9.64%	35.18%
AFX	65 Neutral	€2.35B	26.13	6.77%	1.50%	7.82%	-19.80%
COP	60 Neutral	€1.43B	49.55	4.19%	0.20%	1.16%	-43.53%
SHL	57 Neutral	€42.17B	27.87	11.65%	2.13%	4.53%	10.12%
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
SBS	49 Neutral	€213.46M	58.01	6.55%	2.71%	-1.64%	22.60%